IRIS
PITTALUGA, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 23.199
Totale 23.199
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 23.199
Totale 23.199
Salva come PNG Salva come JPEG
Città #
Genova 16.103
Rapallo 2.959
Genoa 2.408
Vado Ligure 1.669
Bordighera 60
Totale 23.199
Salva come PNG Salva come JPEG
Nome #
Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 165
Glycine modulates 3H-noradrenaline release in rat hippocampus through a strychnine-sensitive receptor 159
CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice 156
Environmental Training And Synaptic Functions In Young And Old Brain: A Presynaptic Perspective 154
Dangerous liaisons between beta-amyloid and cholinergic neurotransmission 149
Chronic nicotine exposure selectively activates a carrier-mediated release of endogenous glutamate and aspartate from rat hippocampal synaptosomes 148
Compensatory Molecular and Functional Mechanisms in Nervous System of the Grm1crv4 Mouse Lacking the mGlu1 Receptor: A Model for Motor Coordination Deficits. 147
In vitro exposure to nicotine induces endocytosis of presynaptic AMPA receptors modulating dopamine release in rat Nucleus Accumbens nerve terminals 146
Somatostatin-induced activation and up-regulation of N-methyl-D-aspartate receptor function: mediation through calmodulin-dependent protein kinase II, phospholipase C, protein kinase C, and tyrosine kinase in hippocampal noradrenergic nerve endings. 144
Presynaptic mGlu1 Receptors Control GABAB Receptors in an Antagonist-Like Manner in Mouse Cortical GABAergic and Glutamatergic Nerve Endings 143
Heterologous carriers located on rat CNS nerve endings and their possible role in the modulation of transmitter release 139
THe human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-D-aspartate receptors mediating noradrenaline release in the hippocampus 138
Somatostatin inhibits glutamate release from mouse cerebrocortical nerve endings through presynaptic sst2 receptors linked to the adenylyl cyclase-protein kinase A pathway 138
L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors 137
Anxiety-Like Behavior of Prenatally Stressed Rats Is Associated with a Selective Reduction of Glutamate Release in the Ventral Hippocampus 136
Presynaptic receptors modulating transmitter release: physiological and pharmacological aspects 135
Exposure to predator odor and resulting anxiety enhances the expression of the α2δ subunit of voltage-sensitive calcium channels in the amygdala 135
Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine 134
RANTES-mediated control of excitatory amino acid release in mouse spinal cord 134
Hippocampal AMPA autoreceptors positively coupled to NMDA autoreceptors traffic in a constitutive manner and undergo adaptative changes following enriched environment training. 134
Prophylactic versus therapeutic fingolimod: Restoration of presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis 133
Environmental training is beneficial to clinical symptoms and cortical presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis 132
Salvinorin A modulates the neurotransmitters release from different mouse brain areas through presynaptic metabotropic receptors activation. 130
An innovative green extraction and re-use strategy to valorize food supplement by-products: Castanea sativa bud preparations as case study 130
Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate release 129
N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus. 129
Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABAB receptor antagonists 128
Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus 128
Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central CCL5 overproduction. 127
The HIV-1 viral protein Tat modulates glutamate and GABA exocytosis from human and mouse neocortical nerve endings by acting at different binding sites. 126
CXCR4 and NMDA Receptors Are Functionally Coupled in Rat Hippocampal Noradrenergic and Glutamatergic Nerve Endings 126
Effects of the HIV-1 viral protein TAT on central neurotransmission: role of group I metabotropic glutamate receptors. 126
Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain 124
Serotonin-glutamate interactions in rat cerebellum: involvement of multiple 5-HT receptor subtypes 123
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 123
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus 122
Effects of the neoclerodane Hardwickiic acid on the presynaptic opioid receptors which modulate noradrenaline and dopamine release in mouse central nervous system 122
The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection. 121
HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings 121
Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals in hippocampus 121
Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathies 121
AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram) 120
Activation of presynaptic oxytocin receptors enhances glutamate release in the ventral hippocampus of prenatally restraint stressed rats 119
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus 119
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition 118
RANTES modulates the release of glutamate in human neocortex. 118
Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders 118
Characterization of two central AMPA-preferring receptors having distinct location, function and pharmacology 118
The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release. 118
[3H]Pirenzepine binding in rat corpus striatum decreases after hemitransection of the nigro-striatal pathway 117
Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120 117
Ellagic acid a multi-target bioactive compound for drug discovery in CNS? A narrative review 117
Presynaptic mGlu1 and mGlu5 autoreceptors facilitate glutamate exocytosis from mouse cortical nerve endings. 117
Clonidine differentially modulates the release of endogenous GABA in various rat brain areas 116
Microdispersions of ellagic acid and pomegranate extracts as new potential nutraceutical ingredients 116
Serotonin receptors regulating transmitter release 115
Extracellular protons differentially potentiate the responses of native AMPA receptor subtypes regulating neurotransmitter release 114
Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors 113
Immuno-Pharmacological Characterization of Presynaptic GluN3A-Containing NMDA Autoreceptors: Relevance to Anti-NMDA Receptor Autoimmune Diseases 113
The Effects of Antidepressant Treatment in Prenatally Stressed Rats Support the Glutamatergic Hypothesis of Stress-Related Disorders 112
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 111
CCL5-glutamate cross-talk in astrocyte-neuron communication in multiple sclerosis 111
< i> In vitro exposure to nicotine modulate the function of presynaptic NMDA receptors present on dopaminergic terminals in rat Nucleus Accumbens 111
Immuno-pharmacological characterization of group II metabotropic glutamate receptors controlling glutamate exocytosis in mouse cortex and spinal cord 111
Antibody/receptor protein immunocomplex in human and mouse cortical nerve endings amplifies complement-induced glutamate release 109
Exposure to an enriched environment selectively increases the functional response of the pre-synaptic NMDA receptors which modulate noradrenaline release in mouse hippocampus 108
Prolonged nicotine exposure down-regulates presynaptic \NMDA\ receptors in dopaminergic terminals of the rat nucleus accumbens 107
Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals 107
The selective disruption of presynaptic JNK2/STX1a interaction reduces NMDA receptor-dependent glutamate release 107
Pharmacological heterogeneity of release-regulating presynaptic AMPA/kainate receptors in the rat brain: study with receptor antagonists 107
Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals 105
Hedonic sensitivity to natural rewards is affected by prenatal stress in a sex-dependent manner 104
CCL5-glutamate crosstalk and presynaptic defects in EAE mice 104
The human immunodeficiency virus-1 protein Tat and its discrete fragments evoke selective release of acetylcholine from human and rat cerebrocortical terminals through species-specific mechanisms 104
Functional adaptation of presynaptic chemokine receptors in EAE mouse central nervous system 104
Competitive inhibition of N-acetylated-alpha-linked acidic dipeptidase activity by N-acetyl-L-aspartyl-beta-linked L-glutamate 103
Activity of putative cognition enhancers in kynurenate test performed with human neocortex slices 103
Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function 102
Presynaptic glycine-dependent NMDA receptors mediate enhancement of the release of [3H]NA from noradrenergic terminals of rat hippocampus 102
Presynaptic glycine GlyT1 transporter – NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions 101
5-HT2A-mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: A 5-HT2Ato mGlu2/3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis 101
Characterization data of water-soluble hydrophilic and amphiphilic dendrimers prodrugs for delivering bioactive chemical entities otherwise non soluble. 101
Alpha-adrenergic regulation of the GABA endogenous release in different rat cerebral cortex subregions. 100
CCL5-mediated control of glutamatergic transmission in EAE mouse central nervous system 100
The reduction in glutamate release is predictive of cognitive and emotional alterations that are corrected by the positive modulator of AMPA receptors S 47445 in perinatal stressed rats 100
Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals 99
GroupI metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 98
Muscarinic receptors mediating inhibition of GABA release in rat corpus striatum and their pharmacological characterization 97
Modulation of central noradrenaline and serotonin release by two subtypes of presynaptic alpha2-adrenergic receptors 97
“Pyrgy” EU project: a website for the divulgation of knowledge of Ligurian medicinal plants and masterpieces. 97
Respective contributions of neuronal activity and presynaptic mechanisms in the control of the in vivo release of dopamine 97
Regulation of dopamine release by muscarinic receptors 96
The human immunodeficiency virus-1 protein Tat upregulates NMDA receptor function by acting at mGluR1 receptors coexisting on human and rat brain noradrenergic neurones 96
Choline increases endogenous GABA release in rat hippocampus by a mechanism sensitive to hemicolinium-3. 95
Compensatory molecular and functional mechanisms in neurons of the Grm1crv4 mouse, a murine model for ataxia lacking the mGlu1 receptor. 94
Presynaptic kynurenate-sensitive receptors inhibit glutamate release 94
Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum 93
Somatostatin potentiates NMDA receptor function via activation of InsP3 receptors and PKC leading to removal of the Mg2+ block without depolarization 93
Changes of neurotransmitter release in the old rat brain and effects of phosphatidylserine treatment 93
A new specific neuronal modulatory effect of nicotine: the functional cross talk between nicotinic and glutamate receptors 92
Totale 11.782
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.026
article - articoli 46.462
book - libri 0
conference - conferenze 27.171
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.393
Totale 154.052
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.717 0 0 0 0 416 520 939 313 435 1.137 760 197
2020/20211.648 92 145 86 96 103 167 205 142 205 138 144 125
2021/20223.318 78 262 213 350 151 212 162 834 147 299 133 477
2022/20233.565 369 277 52 330 544 603 43 250 647 26 382 42
2023/20241.829 106 253 37 244 159 326 109 127 68 55 105 240
2024/20251.756 153 403 143 355 702 0 0 0 0 0 0 0
Totale 23.803